Clinical Trial Update: A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder [Phase 1]

View source ↗

Summary

GlaxoSmithKline completed a Phase 1 study evaluating the interaction between two medications for treating overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Overactive Bladder | Phase 1 | Status: COMPLETED